Skip to main content

Together we are beating cancer

Donate now

Cancer News

Phil Prime

Showing 12 out of 103 results
This entry is part 3 of 10 in the series Diversity in research
%postcontent%

This episode features CRUK Chairman, Professor Sir Leszek Borysiewicz. Following a distinguished academic and clinical research career, Leszek’s roles have included Chief Executive of the Medical Research Council and Vice Chancellor of the University of Cambridge. He talks about the development of the HPV vaccine, the difficulties of navigating a research career and why we must start to embrace failure… even a negative result, he says, is positive. This episode features CRUK Chairman, Professor Sir Leszek Borysiewicz. Following a distinguished academic and clinical research career, Leszek’s roles have included Chief Executive of the Medical Research Council and Vice Chancellor of the University of Cambridge. He talks about the development of the HPV vaccine, the difficulties of navigating a research career and why we must start to embrace failure… even a negative result, he says, is positive.

by Phil Prime | Podcast | 20 July 2022

20 July 2022

This entry is part 4 of 9 in the series Cancer Research Matters - series 1
%postcontent%

We recently welcomed some early career researchers to observe some of the panel discussions and interviews for our Research Careers Committee. So, how did they get on? We recently welcomed some early career researchers to observe some of the panel discussions and interviews for our Research Careers Committee. So, how did they get on?

by Phil Prime | In depth | 6 July 2022

6 July 2022

Nobody fully understands why people go off food in response to infection, early pregnancy and some chemotherapies for cancer. A flurry of research published in recent years has narrowed down the search for the culprit mechanism, and Cancer Research UK-funded researchers have just found another piece of the puzzle. Nobody fully understands why people go off food in response to infection, early pregnancy and some chemotherapies for cancer. A flurry of research published in recent years has narrowed down the search for the culprit mechanism, and Cancer Research UK-funded researchers have just found another piece of the puzzle.

by Phil Prime | In depth | 15 June 2022

15 June 2022

This episode features Professor Sara Zanivan. She talks about how understanding the tumour microenvironment has developed over the past 20 years, how the techniques of proteomics have really freed researchers to ask the important questions and why we could even see mass-spec proteomics in the clinic. This episode features Professor Sara Zanivan. She talks about how understanding the tumour microenvironment has developed over the past 20 years, how the techniques of proteomics have really freed researchers to ask the important questions and why we could even see mass-spec proteomics in the clinic.

by Phil Prime | Podcast | 23 May 2022

23 May 2022

This entry is part 3 of 9 in the series Cancer Research Matters - series 1
%postcontent%

Find out what a Registered Report is, how you can get involved, and why this relatively small change in the way research is done could have a real impact on reproducibility issues and even patient outcomes. Find out what a Registered Report is, how you can get involved, and why this relatively small change in the way research is done could have a real impact on reproducibility issues and even patient outcomes.

by Phil Prime | Interview | 16 May 2022

16 May 2022

Executive Director of Research and Innovation, Iain Foulkes introduces our new innovation engine – Cancer Research Horizons Executive Director of Research and Innovation, Iain Foulkes introduces our new innovation engine – Cancer Research Horizons

by Phil Prime | Analysis | 3 May 2022

3 May 2022

We invited our clinical research community to pose us questions to make sure we are doing all we can to help the recovery of cancer clinical trials to pre-pandemic levels We invited our clinical research community to pose us questions to make sure we are doing all we can to help the recovery of cancer clinical trials to pre-pandemic levels

by Phil Prime | Interview | 29 April 2022

29 April 2022

We are jointly funding a follow-up study which will find the final evidence on the impact on oesophageal cancer mortality of screening using the Cytosponge. We are jointly funding a follow-up study which will find the final evidence on the impact on oesophageal cancer mortality of screening using the Cytosponge.

by Phil Prime | In depth | 28 April 2022

28 April 2022

Cancer Research UK is making it easier for the cancer research community to both contribute and access research tools Cancer Research UK is making it easier for the cancer research community to both contribute and access research tools

by Phil Prime | In depth | 11 April 2022

11 April 2022

We spoke to Professor Andrew Tutt about how you build a successful scientific team, the importance of translation and why you always need a touch of humbleness… We spoke to Professor Andrew Tutt about how you build a successful scientific team, the importance of translation and why you always need a touch of humbleness…

by Phil Prime | Interview | 10 April 2022

10 April 2022